ReviewNanoscale2025
Advancing transistor-based point-of-care (POC) biosensors: additive manufacturing technologies and device integration strategies for real-life sensing.
Review in Nanoscale, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Electrochemical Biosensors for Circulating Tumor Cells and ctDNA: Emerging Strategies for Precision Oncology.Annals of biomedical engineering · 2026Review
- Organic Electrochemical Transistors for Neuromorphic Bioelectronics: Materials and Manufacturing Technologies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Review
- Aerosol Jet Printing in Biotechnologies.Bioengineering (Basel, Switzerland) · 2026Review
- Enzyme-Triggered In Situ Assembly of FeBiosensors · 2026Article
- Next-Generation Bionic Sensors for Small Molecule Detection: Integrating Synthetic Biology, Nanomaterials, and Artificial Intelligence.Micromachines · 2026Review
- Recent Advances in Graphene-Based Field-Effect Transistor Biosensors for Disease Biomarker Detection and Clinical Prospects.Biosensors · 2026Review
- Challenges of Wearable Biosensors and Ways to Overcome Them.Biosensors · 2026Review
- Printing technologies for monitoring crop health.Nature communications · 2026Review
- Symptoms and causes of obstacles in AI-based telemonitoring: strategies for system development through a CRISP-DM lens.Frontiers in artificial intelligence · 2026Article
- Logic Circuits Featuring Organic Electrochemical Transistors: What is the Logic Behind OECTs in Logic?Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Infectious pathogens pose a significant threat to public health and healthcare systems, making the development of a point-of-care (POC) detection platform for their early identification a key focus in recent decades. Among the numerous biosensors developed over the years, transistor-based biosensors, particularly those incorporating nanomaterials, have emerged as promising candidates for POC detection, given their unique electronic characteristics, compact size, broad dynamic range, and real-time biological detection capabilities with limits of detection (LODs) down to zeptomolar levels. However, the translation of laboratory-based biosensors into practical applications faces two primary challenges: the cost-effective and scalable fabrication of high-quality transistor sensors and functional device integration. This review is structured into two main parts. The first part examines recent advancements in additive manufacturing technologies-namely in screen printing, inkjet printing, aerosol jet printing, and digital light processing-and evaluates their applications in the mass production of transistor-based biosensors. While additive manufacturing offers significant advantages, such as high quality, cost-effectiveness, rapid prototyping, less instrument reliance, less material waste, and adaptability to diverse surfaces, challenges related to uniformity and yield remain to be addressed before these technologies can be widely adopted for large-scale production. The second part focuses on various functional integration strategies to enhance the practical applicability of these biosensors, which is essential for their successful translation from laboratory research to commercialization. Specifically, it provides a comprehensive review of current miniaturized lab-on-a-chip systems, microfluidic manipulation, simultaneous sampling and detection, wearable implementation, and integration with the Internet of Things (IoT).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.